FAKTOR OPTIONSSCHEIN - BECTON DICKINSON AND CO. Share Price

Certificat

DE000GK94PF1

Market Closed - BOERSE MUENCHEN 11:56:47 28/06/2024 pm IST
6.055 EUR +2.96% Intraday chart for FAKTOR OPTIONSSCHEIN - BECTON DICKINSON AND CO.
Current month+3.38%
1 month+6.41%
Date Price Change
28/24/28 6.055 +2.96%
27/24/27 5.881 -2.60%
26/24/26 6.038 -1.58%
25/24/25 6.135 -1.65%
24/24/24 6.238 -1.70%

Real-time BOERSE MUENCHEN

Last update June 28, 2024 at 11:56 pm IST

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GK94PF
ISINDE000GK94PF1
Date issued 15/08/2022
Strike 115.5 $
Maturity Unlimited
Parity 18.16 : 1
Emission price 10.03
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 10.5
Lowest since issue 5.53
Spread 0.02
Spread %0.33%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.46%
Consensus